Last reviewed · How we verify
Garcinia mangostana
At a glance
| Generic name | Garcinia mangostana |
|---|---|
| Also known as | Mangosteen |
| Sponsor | Meenakshi Ammal Dental College and Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Mangosteen Supplement as Adjuvant Therapy With Sitagliptin/Metformin in Iraqi Patients With Type 2 Diabetes (NA)
- Evaluation of Mangoselect® in Improvement of Exercise/Activity-induced Knee Joint Discomfort in Subjects Suffering From Osteoarthritis Grade I or II (NA)
- Mangoselect®: Characterization, Pharmacokinetics and Bioavailability of Xanthone Metabolites (NA)
- Garcinia Mangostana L Rind and Solanum Lycopersicum Fructus Trial to Prevent Exercise-induced Oxidative Stress (PHASE2, PHASE3)
- In-vitro Effect of Mangosteen Pericarp Extract on Cell Lines (NA)
- Garcinia Mangostana L.Pericarp Gel as a Local Drug Delivery in Treatment of Chronic Periodontitis (NA)
- Garcinia Mangostana Extracts in the Management of Weight Loss (PHASE4)
- Evaluate Use of Mangosteen Juice Added to Usual Care in Reducing Risk of Recurrent Atrial Fibrillation (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Garcinia mangostana CI brief — competitive landscape report
- Garcinia mangostana updates RSS · CI watch RSS
- Meenakshi Ammal Dental College and Hospital portfolio CI